As marijuana stocks’ impressive run so far this year generates increasing investor interest in the sector, the author of today’s article warns of a danger associated with buying and selling pot stocks, a danger “with which even experienced investors aren’t entirely familiar” and which “can eat into your profits and even turn gains into losses”. That danger? Illiquidity risk. How can you manage illiquidity risk if you want to trade a pot stock not on a major exchange? CLICK HERE.
Facing declining sales in their own industries, and with the global legal cannabis market predicted to be worth $146.4 billion by 2025, tobacco and alcohol companies have been considering – and in some cases making – moves into the cannabis space. Today’s article previews that, this year, “Not only will we see big players entering the sector but there will also be a series of consolidations by large cannabis firms seeking to compete with new entrants” – and highlights one company in the fast-growing CBD sub-sector that may be a particularly tempting acquisition target after the passing of the Farm Bill. For more, CLICK HERE.
“Some will make millions in marijuana stocks, but many more will lose their shirts,” states the author of today’s article, which focuses on the recent run-up in marijuana stocks and how those already invested in marijuana stocks (and those thinking about becoming invested in marijuana stocks) may want to approach it. What does the author identify as the real reason behind the run-up, what do money flows from the “smart money” indicate, and what might various types of pot stock investors – and prospective pot stock investors – want to do now? CLICK HERE.
When 2019 comes to a close, what will have been the biggest developments that impacted marijuana stocks – and which pot stocks will have benefitted the most from those developments? In today’s article, the author provides his answers to those questions – identifying what he believes will be the three critical developments for marijuana stocks to watch this year and the specific stocks that are positioned to be the most likely winners from those developments. For more, CLICK HERE.
With growing social acceptance of marijuana use, and the economic boon legalization has been to states such as Colorado, the author of today’s article believes that “the federal government may just have to reconsider its stance on cannabis” – and proceeds to highlight four marijuana penny stocks that could reap the rewards of such a change in position. For more on these four stocks – including “one of the few names among marijuana penny stocks that’s completely devoted to medicinal marijuana” – CLICK HERE.
Cryptocurrencies and marijuana stocks have more that connects them than the fact that both had impressive showings in 2017. The author of today’s article notes that “what most investors may not realize is that cryptocurrencies and the cannabis industry may soon be tied at the hip. Cryptocurrencies are helping to shape a cannabis industry that’s facing multiple hurdles, especially in the United States where pot is still illegal at the federal level.” The author proceeds to detail “three unique ways cryptocurrencies are attempting to solve major issues for the marijuana industry” – and why this connection is important to investors. CLICK HERE.
In regards to investing in the marijuana industry, the author of today’s article states that, while “we are big believers in where this emerging trend is going in terms of an end result helping people with a myriad of physical ailments and more serious medical conditions…the wrong investment path to that end result could end very badly for investors depending on how they choose to participate in the theme.” So what might be the best investment path when it comes to this nascent industry? CLICK HERE for more.
While Canada is on track to fully legalize marijuana this year – and Canadian marijuana stocks on the whole stand to capitalize – not every company will necessarily be a winner and some Canadian pot stocks could be dangerous. Today’s article highlights one Canadian marijuana stock that – while up 367% over the last two years on expectations of growth – may not be such a “supreme” choice. CLICK HERE for more.
“Wall Street typically shuns most of the OTC-listed marijuana stocks,” admits today’s article. However, that doesn’t mean there aren’t other ways to invest in weed. With most OTC-listed marijuana stocks performing poorly, today’s article offers up three marijuana-connected stocks as alternatives to investing in growers and sellers. One such stock? G.W. Pharmaceuticals, which explores potential medical applications of marijuana and which has a number of potential drug candidates for diseases and disorders such as multiple sclerosis and epilepsy. To read more about this stock, as well as the other two stocks the author highlights, CLICK HERE.